The US Food and Drug Administration (FDA) has granted accelerated approval to Vimkunya™, a recombinant chikungunya vaccine, ...

As a bonus, Bavarian Nordic also gets a priority review voucher from the FDA, awarded as an incentive to carry out drug ...

The US Food and Drug Administration (FDA) has approved Bavarian Nordic’s chikungunya vaccine Vimkunya for use in individuals ...

First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention for younger ...

The European Commission (EC) has already approved Valneva’s chikungunya vaccine Ixchiq for use in individuals aged 18 years ...

First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention for younger travelers.On track for commercial launch in the U.S. in the ...

According to the World Health Organization (WHO), chikungunya is a mosquito-borne viral disease that causes fever, swelling, and joint pain. Like dengue, patients may experience muscle pain, headache, ...

Deadly viruses could become endemic in Europe unless urgent measures are taken, a leading expert has warned. Rising global ...

Here’s a look at Zika virus, an illness spread through mosquito bites that can cause birth defects and other neurological defects. Facts Sources: Centers for Disease Control and Prevention (CDC), ...

First chikungunya vaccine recommended by the CHMP ... the vaccine cannot infect cells, reproduce or cause disease. While the mechanism of action of CHIKV VLP vaccine still needs to be further ...

Valneva’s chikungunya vaccine Ixchiq has been greenlit by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), allowing the single-dose vaccine to be made available for adults.